Filing Details

Accession Number:
0001213900-23-021235
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-20 08:02:25
Reporting Period:
2023-03-17
Accepted Time:
2023-03-20 08:02:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711754 Inmune Bio Inc. INMB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421930 J David Moss C/O Inmune Bio Inc.
225 Ne Mizner Blvd., Suite 640
Boca Raton FL 33432
Cfo, Treasurer & Secretary No Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-17 2,500 $6.43 1,250,151 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Reporting Person purchased 2,500 shares of the Issuer's Common Stock in an open market transaction on March 17, 2023.